Kaplan–Meier analysis of overall mortality (Fig. 6B) revealed that patients with high tumor SNAT2 expression have a significantly poorer outcome compared with patients with low tumor SNAT2 expression (for trend, P = 0.034), with a similar pattern seen in ER+ patients (Fig. 6B). This evidence concerns the gene ESR1 and neoplasm.